{"entity":{"id":"regenerate-pancreatic-genetics-mced","kind":"trial","name":"REGENERATE (genetic and multi-cancer test education for people at pancreatic cancer risk)","aka":["REGENERATE"],"tldr":"A small randomised study of how to help people at higher risk of pancreatic cancer decide about genetic testing and a multi-cancer blood test.","summary":"REGENERATE (NCT07787156) is a randomised interventional study sponsored by Brigham and Women's Hospital with Pancreatic Cancer Action Network, Exact Science Corporation, Dana-Farber Cancer Institute and others. Its primary outcomes are the feasibility of completing genetic and multi-cancer testing, acceptability and fidelity; Exact Sciences and the Pancreatic Cancer Action Network are collaborators.\n\nThe registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 80 participants, a start on 15 October 2026 and primary completion expected in September 2028.","status":"recruiting","asOf":"2026-10-29","links":[{"label":"ClinicalTrials.gov NCT07787156","url":"https://clinicaltrials.gov/study/NCT07787156"}],"tags":[],"related":[],"cancers":["pancreatic"],"sections":["early-detection"],"technologies":["mced","liquid-biopsy","germline-testing"],"targets":[],"drugs":[],"companies":["exact-sciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07787156","phase":"not-applicable","setting":"Black, Latino/a and Medicaid-enrolled people in Massachusetts who may be at higher risk of pancreatic cancer, randomised to online education alone or with a phone session before choosing genetic testing and multi-cancer testing","sponsor":"Brigham and Women's Hospital with Pancreatic Cancer Action Network, Exact Science Corporation, Dana-Farber Cancer Institute, Winn Career Development Award","started":"2026-10-15","startedType":"actual","enrolled":80,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/regenerate-pancreatic-genetics-mced/","neighbours":{"cancer":[{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"}],"section":[{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"germline-testing","kind":"technology","name":"Germline (hereditary) testing","route":"/technologies/germline-testing/"},{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"},{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"}],"company":[{"id":"exact-sciences","kind":"company","name":"Exact Sciences (Abbott)","route":"/companies/exact-sciences/"}]}}